|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.24 USD | -2.66% |
|
-4.29% | -4.99% |
| Apr. 04 | Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge | MT |
| Apr. 04 | Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge | CI |
Haemonetics Corporation (NYSE:HAE) announces a share repurchase program. Under the program, the company will repurchase up to $300 million worth of its shares. The purpose of the program is to offset the dilutive impact of recent and future employee equity grants.
The program will be valid for a period of three years.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.99% | 4.24B | |
| -2.53% | 183B | |
| -3.52% | 105B | |
| +5.33% | 51.77B | |
| +16.43% | 47.29B | |
| -1.73% | 40.2B | |
| +5.66% | 27.62B | |
| -2.01% | 25.51B | |
| +9.84% | 24.73B | |
| -1.87% | 24.52B |
HAEMONETICS CORPORATION 
